Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial

Hurvitz, S. A.; Quek, R. G. W.; Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E.; Mina, L. A.; Balmana, J.; Fasching, P. A.; Bhattacharyya, H.; Hannah, A. L.; Robson, M. E.; Wardley, A. M.

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2019-08-03T08:40:53Z
dc.date.available	2019-08-03T08:40:53Z
dc.date.issued	2018
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/91271
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2018.09.003	de_DE
dc.subject.ddc	610	de_DE
dc.title	Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00558
utue.publikation.seiten	160-168	de_DE
utue.personen.roh	Hurvitz, S. A.
utue.personen.roh	Quek, R. G. W.
utue.personen.roh	Turner, N. C.
utue.personen.roh	Telli, M. L.
utue.personen.roh	Rugo, H. S.
utue.personen.roh	Mailliez, A.
utue.personen.roh	Ettl, J.
utue.personen.roh	Grischke, E.
utue.personen.roh	Mina, L. A.
utue.personen.roh	Balmana, J.
utue.personen.roh	Fasching, P. A.
utue.personen.roh	Bhattacharyya, H.
utue.personen.roh	Hannah, A. L.
utue.personen.roh	Robson, M. E.
utue.personen.roh	Wardley, A. M.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	104	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE